Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lysozyme for COPD Exacerbation
NCT01645800Phase 4Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Aug 2012
- Primary completion
- Jan 2015
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of lysozyme in chronic obstructive pulmonary disease (COPD), sponsored by Eisai Co., Ltd.. Started Aug 2012; status: completed.
02
Drugs
lysozyme
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01645800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01645800.